aod9604 phase 2b trial results weight loss AOD 9604: Peptide Claims vs Clinical Reality, AOD 9604 is marketed as a fat-metabolism peptide derived from a growth hormone fragment, often positioned as “HGH-like” without HGH’s side effects. The AOD 9604 Peptide for Fat

While oral bioavailability is lower than subcutaneous administration, these studies established that even high oral doses maintained excellent safety profiles, though higher doses (54 mg) were associated with increased gastrointestinal discomfort

Minimum 95% purity verified by third-party HPLC-MS analysis, with certificates of analysis included with every batch

Potential Research Applications: Glucose metabolism and insulin sensitivity studies Mitochondrial function and energy regulation research Aging, longevity, and metabolic health models Exercise mimetic and fat metabolism investigations For laboratory research use only

Obese individuals often exhibit both elevated NNMT in adipose tissue and impaired muscle regenerative capacity a connection that NNMTs dual tissue effects could help explain

These nutrient-rich formulations are promoted for their potential to support energy levels, metabolic efficiency, and fat mobilization